Sponsor content

OncoQuest aims to enhance the success of cancer immunotherapy

This Canadian biotechnology company is developing combination-treatment strategies based on monoclonal antibodies to improve clinical outcomes for cancer patients. To download the full article, please sign in.

Go to the profile of OncoQuest Inc
Mar 01, 2016
1
0
Upvote 1 Comment
Page of
Go to the profile of OncoQuest Inc

OncoQuest Inc

Canadian biotechnology company developing combination-treatment strategies based on monoclonal antibodies to improve clinical outcomes for cancer patients.
0 Contributions
6 Followers
0 Following

Please sign in or register for FREE to comment